153 related articles for article (PubMed ID: 9691827)
1. [Allergic rhinoconjunctivitis treated with intramuscular injection of glucocorticoid].
Dahl M; Laursen LC
Ugeskr Laeger; 1998 Jul; 160(28):4231-3. PubMed ID: 9691827
[TBL] [Abstract][Full Text] [Related]
2. [Glucocorticoid injections in the treatment of seasonal allergies].
Aadal M; Slørdal L
Tidsskr Nor Laegeforen; 2014 Jan; 134(2):186-8. PubMed ID: 24477154
[No Abstract] [Full Text] [Related]
3. Injectable depot corticosteroid therapy in hay fever.
Kronholm A
J Int Med Res; 1979; 7(4):314-7. PubMed ID: 385402
[TBL] [Abstract][Full Text] [Related]
4. Treatment of seasonal allergic rhinitis with long-acting steroid injections. A comparison of four preparations.
Chervinsky P
Ann Allergy; 1968 Apr; 26(4):190-3. PubMed ID: 5644715
[No Abstract] [Full Text] [Related]
5. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients.
Laursen LC; Faurschou P; Pals H; Svendsen UG; Weeke B
Allergy; 1987 Apr; 42(3):168-72. PubMed ID: 3592139
[TBL] [Abstract][Full Text] [Related]
6. A comparison of three injectable corticosteroids for the treatment of patients with seasonal hay fever.
Ohlander BO; Hansson RE; Karlsson KE
J Int Med Res; 1980; 8(1):63-9. PubMed ID: 7358206
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of hay-fever with depot corticosteroids (author's transl)].
Brenn H
Schweiz Rundsch Med Prax; 1977 Jan; 66(3):82-5. PubMed ID: 834719
[No Abstract] [Full Text] [Related]
8. Seasonal allergic rhinitis: limited effectiveness of treatments.
Prescrire Int; 2008 Feb; 17(93):28-32. PubMed ID: 18383656
[TBL] [Abstract][Full Text] [Related]
9. Comparison of oral and depot intra-muscular steroids in assessing steroid-responsiveness in COPD.
Eiser N; Phillips C; Wooler P; Partridge M
COPD; 2004 Apr; 1(1):33-40. PubMed ID: 16997737
[TBL] [Abstract][Full Text] [Related]
10. [Systemic steroid therapy in allergic rhinitis].
Wikström-Jonsson E; Vitols S
Lakartidningen; 2006 Mar 1-7; 103(9):661. PubMed ID: 16583543
[No Abstract] [Full Text] [Related]
11. Intramuscular betamethasone dipropionate vs. topical beclomethasone dipropionate and placebo in hay fever.
Laursen LC; Faurschou P; Munch EP
Allergy; 1988 Aug; 43(6):420-4. PubMed ID: 3189722
[TBL] [Abstract][Full Text] [Related]
12. Injectable steroids in allergy.
Grater WC; Brown EB
Ann Allergy; 1969 Jul; 27(7):321-7. PubMed ID: 4978520
[No Abstract] [Full Text] [Related]
13. Still no place for depot triamcinolone in hay fever?
Wan Y
Drug Ther Bull; 2020 Apr; 58(4):57-59. PubMed ID: 32051146
[TBL] [Abstract][Full Text] [Related]
14. Short-term use of oral and depo methylprednisolone in allergic rhinitis and asthma.
Miller J
Curr Ther Res Clin Exp; 1971 Mar; 13(3):188-92. PubMed ID: 4998291
[No Abstract] [Full Text] [Related]
15. Depot corticosteroid preparations in hay fever.
Melotte G
Practitioner; 1973 Feb; 210(256):282-5. PubMed ID: 4690780
[No Abstract] [Full Text] [Related]
16. [Letter: Intramuscular corticoides in hay fever?].
Kaiser H
Dtsch Med Wochenschr; 1976 Apr; 101(16):630. PubMed ID: 1261386
[No Abstract] [Full Text] [Related]
17. Intra-articular corticosteroid preparations: different characteristics and their effect during inflammation induced by monosodium urate crystals in the rat subcutaneous air pouch.
Rull M; Clayburne G; Sieck M; Schumacher HR
Rheumatology (Oxford); 2003 Sep; 42(9):1093-100. PubMed ID: 12777646
[TBL] [Abstract][Full Text] [Related]
18. [Effectiveness and tolerability of the glucocorticoid mometasone furoate given as nasal spray in seasonal allergic rhinitis].
Magyar P; Herjavecz I; Hirschberg A; Kraszkó P; Mohácsi E; Nékám K; Fónay K; Berta G; Györi Z; Márk Z
Orv Hetil; 2000 Jun; 141(25):1407-11. PubMed ID: 10934885
[TBL] [Abstract][Full Text] [Related]
19. Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording.
Borum P; Grønborg H; Mygind N
Allergy; 1987 Jan; 42(1):26-32. PubMed ID: 3551670
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of topical glucocorticoid treatment of hay fever: IL-5 and eosinophil activation during natural allergen exposure are suppressed, but IL-4, IL-6, and IgE antibody production are unaffected.
Kita H; Jorgensen RK; Reed CE; Dunnette SL; Swanson MC; Bartemes KR; Squillace D; Blomgren J; Bachman K; Gleich GJ
J Allergy Clin Immunol; 2000 Sep; 106(3):521-9. PubMed ID: 10984373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
